Tenax Therapeutics, Inc. (TENX)
1.85
-0.02
(-1.07%)
USD |
NASDAQ |
Oct 12, 13:21
Tenax Therapeutics Free Cash Flow (Quarterly) : -14.15M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.15M |
| March 31, 2026 | -9.309M |
| December 31, 2025 | -13.42M |
| September 30, 2025 | -9.155M |
| June 30, 2025 | -6.263M |
| March 31, 2025 | -6.967M |
| December 31, 2024 | -3.527M |
| September 30, 2024 | -3.087M |
| June 30, 2024 | -3.031M |
| March 31, 2024 | -5.166M |
| December 31, 2023 | -1.174M |
| September 30, 2023 | -2.081M |
| June 30, 2023 | -0.923M |
| March 31, 2023 | -1.725M |
| December 31, 2022 | -2.309M |
| September 30, 2022 | -3.331M |
| June 30, 2022 | -3.431M |
| March 31, 2022 | -2.944M |
| December 31, 2021 | -2.770M |
| September 30, 2021 | -3.023M |
| June 30, 2021 | -1.847M |
| March 31, 2021 | -3.221M |
| December 31, 2020 | -1.991M |
| September 30, 2020 | -2.385M |
| June 30, 2020 | -2.229M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.671M |
| December 31, 2019 | -1.726M |
| September 30, 2019 | -1.782M |
| June 30, 2019 | -1.915M |
| March 31, 2019 | -2.136M |
| December 31, 2018 | -1.199M |
| September 30, 2018 | -1.556M |
| June 30, 2018 | -1.190M |
| March 31, 2018 | -1.562M |
| December 31, 2017 | -1.282M |
| September 30, 2017 | -1.227M |
| June 30, 2017 | -5.595M |
| March 31, 2017 | -4.041M |
| December 31, 2016 | -3.105M |
| September 30, 2016 | -4.281M |
| June 30, 2016 | |
| July 31, 2015 | -3.860M |
| April 30, 2015 | -1.642M |
| January 31, 2015 | -3.253M |
| October 31, 2014 | -2.962M |
| July 31, 2014 | -1.998M |
| April 30, 2014 | -3.014M |
| January 31, 2014 | -2.750M |
| October 31, 2013 | -2.049M |
| July 31, 2013 | -1.596M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Exicure, Inc. | -0.887M |
| Century Therapeutics, Inc. | -20.53M |
| Absci Corp. | -27.56M |
| Celularity, Inc. | 1.447M |
| Cardio Diagnostics Holdings, Inc. | -1.389M |